Greater consumption of sugar-sweetened beverages was associated with a 34% increased risk for anxiety disorders, a ...

You will want the facts up front: a former Britain’s Got Talent dancer was arrested on suspicion of child sex offences and ...

Third, Fava concludes, excessive reliance on checklist criteria is likely to “impoverish the clinical process” and clinical formulation itself, including of the kind that could anchor a patient’s ...

In a phase 3 trial, 25 mg of COMP360 psilocybin significantly improved MADRS scores in treatment-resistant depression compared with a 1 mg dose.

NEW HAVEN, Conn., Feb. 19, 2026 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company ...

AI can be used to produce mental health treatment plans. That's already happening. The next era is using neuro-symbolic AI. I ...

Today, Compass updated investors on its drug trial progress, and the stock shot higher. Compass announced two Phase 3 trials ...

The Food and Drug Administration has approved Vybrique (sildenafil) oral film for the treatment of erectile dysfunction.

NRx together with Osmind, Inc. conducted an in-person meeting attended by leadership of the FDA Division of Psychiatry ...

Neurocrine Biosciences, Inc. leverages a strong cash position and a neuropsychiatry pipeline to drive long-term commercial ...

Evecxia Therapeutics, Inc.—a clinical-stage neuroscience company developing a novel class of Serotonin Synthesis ...